Selective inactivation of p53 facilitates mouse epithelial tumor progression without chromosomal instability

Molecular and Cellular Biology

Volumn 21, Issue 17, 2001, Pages 6017-6030

  Lu, X ^a   Magrane, G ^a   Yin, C ^a   Louis, D N ^a   Gray, J ^a   Van Dyke, T ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN TUMOR; CARCINOGENESIS; CHROMOSOME 11; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DIPLOIDY; EPITHELIUM TUMOR; GENE INACTIVATION; HETEROZYGOSITY LOSS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; BRAIN NEOPLASMS; CHROMOSOMES; DISEASE PROGRESSION; MICE; NEOPLASMS, EXPERIMENTAL; NEOPLASMS, GLANDULAR AND EPITHELIAL; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 0034909856     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.17.6017-6030.2001     Document Type: Article

References (75)

1. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
2. p53 in signaling checkpoint arrest or apoptosis
3. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome
4. Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: Aneuploidy and immortalization
5. How tumors become angiogenic
6. Spontaneous and ionizing radiation-induced chromosomal abnormalities in p53-deficient mice
7. Radiation-induced cell cycle arrest compromised by p21 deficiency
8. Loss of heterozygosity and mutational alterations of the p53 gene in the skin tumors of interspecific hybrid mice
9. Chk2/ hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53
10. Lymphotropic papovavirus early region is specifically regulated in transgenic mice and efficiently induces neoplasia
11. Uniform cell-autonomous tumorigenesis of the choroid plexus by papovavirus large T antigens
12. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1
13. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B
14. Mice lacking p21CIP/WAF1 undergo normal development, but are defective in G1 checkpoint control
15. DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function
16. Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability
17. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
18. Chromosomal instability is correlated with telomere erosion and inactivation of G2 checkpoint function in human fibroblasts expressing human papillomavirus type 16 E6 oncoprotein
19. Genome screening by comparative genomic hybridization
20. Abnormal centrosome amplification in the absence of p53
21. Genomic instability and apoptosis are frequent in p53 deficient young mice
22. p53; from inductive signal to cellular effect
23. Cell cycle control and cancer
24. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice
25. 14-3-3 Sigma is a p53-regulated inhibitor of G2/M progression
26. DNA damage-induced activation of p53 by the checkpoint kinase Chk2
27. Somatic point mutations in the p53 gene of human tumors and cell lines: Updated compilation
28. Apoptosis or retinoblastoma: Alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53
29. Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53
30. Tumor spectrum analysis in p53-mutant mice
31. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
32. p53, guardian of the genome
33. Mitotic checkpoint inactivation fosters transformation in cells lacking the breast cancer susceptibility gene, Brca2
34. Genetic instabilities in human cancers
35. The p53 tumour suppressor gene
36. p53, the cellular gatekeeper for growth and division
37. No requirement for V(D)J recombination in p53-deficient thymic lymphoma
38. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
39. Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells
40. Mouse models dissect the role of p53 in cancer and development
41. Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system
42. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens
43. Mutations in the p53 gene occur in diverse human tumor types
44. p53 wild-type and p53 nullizygous big blue transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen, and brain
45. Direct involvement of p53 in the base excision repair pathway of the DNA repair machinery
46. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: Implications for tumor suppressor gene function in development
47. Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development
48. A key role for E2F1 in p53-dependent apoptosis and cell division within developing tumors
49. Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage
50. The p53 pathway
51. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha
52. Essential role for p53-mediated transcription in EIA-induced apoptosis
53. Induction versus progression of brain tumor development: Differential functions for the pRB- and p53-targeting domains of simian virus 40 T antigen
54. p53 deficiency does not affect the accumulation of point mutations in a transgene target
55. p53-dependent cell cycle control: Response to genotoxic stress
56. A targeted disruption of the murine Brcal gene causes gamma-irradiation hypersensitivity and genetic instability
57. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites
58. Cloning and characterization of BA12 and BA13, novel genes homologous to brain-specific angiogenesis inhibitor 1 (BAI1)
59. p53-dependent apoptosis suppresses tumor growth and progression in vivo
60. p53 inhibits entry into mitosis when DNA synthesis is blocked
61. Enhanced proliferative potential in culture of cells from p53-deficient mice
62. Relationship between simian virus 40 large tumor antigen expression and tumor formation in transgenic mice
63. Retention of wild-type p53 in tumors from p53 heterozygous mice: Reduction of p53 dosage can promote cancer formation
64. Surfing the p53 network
65. Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity
66. p53: Death star
67. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21 waf1/cip
68. p53 modulation of TFIIH-associated nucleotide excision repair activity
69. The retinoblastoma protein and cell cycle control
70. Cooperative tumourigenic effects of germline mutations in Rb and p53
71. Conditional mutation of Brcal in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation
72. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles
73. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression
74. p53 regulates the expression of the tumor suppressor gene maspin